Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Conditions
Interventions
PF-06372865
Placebo
+1 more
Locations
46
United States
Agave Clinical Research, LLC
Mesa, Arizona, United States
Arizona Research Center, Inc.
Phoenix, Arizona, United States
Global Research
Anaheim, California, United States
Neuro-Pain Medical Center
Fresno, California, United States
Providence Clinical Research
North Hollywood, California, United States
Elite Clinical Trials, Incorporate
Wildomar, California, United States
Start Date
October 1, 2014
Primary Completion Date
August 1, 2015
Completion Date
August 1, 2015
Last Updated
January 4, 2017
NCT03836248
NCT07132762
NCT06419439
NCT06384001
NCT07163117
NCT06630676
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions